Early Change in Depressive Symptom Severity With Naltrexone-Bupropion Combination and Its Association With Reduction in Methamphetamine Use in ADAPT-2 Trial
Authors
Thomas Carmody (ORCID: https://orcid.org/0000-0003-3256-8269)
Udi E. Ghitza (ORCID: https://orcid.org/0000-0001-9964-8066)
Sidarth Wakhlu
Joy M. Schmitz (ORCID: https://orcid.org/0000-0002-3561-4614)
Early Change in Depressive Symptom Severity With Naltrexone-Bupropion Combination and Its Association With Reduction in Methamphetamine Use in ADAPT-2 Trial
Thomas Carmody, Udi E. Ghitza, Sidarth Wakhlu, Joy M. Schmitz et al.
Citations
1 citations
Journal
The Journal of Clinical Psychiatry
Topics
Attention Deficit Hyperactivity Disorder
Field-Weighted Citation Impact (FWCI)
1.47
article
Early Change in Depressive Symptom Severity With Naltrexone-Bupropion Combination and Its Association With Reduction in Methamphetamine Use in ADAPT-2 Trial
Thomas Carmody, Udi E. Ghitza, Sidarth Wakhlu, Joy M. Schmitz, Gavin Bart, Manish K. Jha, Phillip O. Coffin, Abu Minhajuddin, Steve Shoptaw, Edward V. Nunes, Madhukar H. Trivedi, Snoben Kuruvila
article en
1 citations
Abstract
No abstract available for this paper.
Publication Tag
The Journal of Clinical PsychiatryVol. 86(3)
Institutions
National Institutes of Health (US), National Institute on Drug Abuse (US), Columbia University Irving Medical Center (US), Southwestern Medical Center (US), The University of Texas Health Science Center (US), Southwestern Medical Center (US), The University of Texas Southwestern Medical Center (US)
Ask Laika to Summarize, Analyze, and Connect papers live on the map.
Summarize Papers & Methodologies
Extract key findings, datasets, and comparative methods across publications.
Benchmark Rankings & Visual Analytics
Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.
Connect Distant Disciplines
Bridge topological clusters on the map to find hidden collaborative intersections.
Early Change in Depressive Symptom Severity With Naltrexone-Bupropion Combination and Its Association With Reduction in Methamphetamine Use in ADAPT-2 Trial — Thomas Carmody, Udi E. Ghitza, et al. · The Journal of Clinical Psychiatry (2025) | TGRS Research Map | TGRS